Dissociating Fibroepithelioma of Pinkus From Internal Malignancy: A Single-Center Retrospective Study

Joseph B Kim1, Austin Gable1, Andrea F McGlynn1

  • 1Drs. Kim, Gable, Logemann, and Hardy are from the Naval Medical Center San Diego, California. Ms. McGlynn is from the Naval Medical Center, Portsmouth, Virginia. Dr. Cantor is from the Walter Reed National Military Medical Center, Bethesda, Maryland. Dr. Walsh is from the Naval Hospital, Sigonella, Italy.

Cutis
|March 22, 2023
PubMed

Insights

Fibroepithelioma of Pinkus (FeP), a rare skin tumor, is not associated with internal gastrointestinal tract tumors. This study found no evidence to support altered cancer screening for patients diagnosed with FeP.

Area of Science:

  • Dermatology
  • Oncology

Background:

  • Fibroepithelioma of Pinkus (FeP) presents clinically similar to benign skin lesions.
  • The potential association between FeP and internal malignancies remains unclear.

Purpose of the Study:

  • To investigate the association between Fibroepithelioma of Pinkus and internal tumors, particularly those of the gastrointestinal tract.

Main Methods:

  • Retrospective review of medical records for patients diagnosed with FeP.
  • Analysis of patient histories for the presence of other tumors up to 2020.

Main Results:

  • The study found no statistically significant association between the presence of Fibroepithelioma of Pinkus and gastrointestinal tract tumors.
  • No correlation was identified to suggest FeP as an indicator for internal malignancies.

Conclusions:

  • Fibroepithelioma of Pinkus does not appear to be a risk factor for developing gastrointestinal tract tumors.
  • Current cancer screening recommendations do not require modification for individuals with FeP.

Related Concept Videos